ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Neuroptika Completes Enrollment of Phase 2 Clinical Trial for Dry Eye Disease
August 20, 2020Neuroptika announced completion of enrollment in a Phase 2 clinical controlled, double-masked trial of NRO-1 for the treatment of patients with dry eye disease. -
Neuroptika Announces Enrollment of First Patient in Dry Eye Disease Trial
January 19, 2020Neuroptika announced the first patient was enrolled in a Phase 2 clinical trial of NRO-1 for the treatment of dry eye disease. NRO-1 is a novel therapeutic with the potential to protect and regenerate corneal nerves in ophthalmic diseases.
Pharma Sources Insight January 2025
